Showing 1 - 13 of 13 Items
Showing 1 - 13 of 13 Items
Sort By: Relevance
Journal Article
|Research
2025-03-25 • Lancet Global Health
2025-03-25 • Lancet Global Health
Journal Article
|Short Report
2024-08-28 • F1000Research
2024-08-28 • F1000Research
BACKGROUND
Tradi...
Journal Article
|Case Report/Series
2024-08-01 • Lancet Infectious Diseases
2024-08-01 • Lancet Infectious Diseases
BACKRGOUND
The rec...
Conference Material
|Abstract
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
BACKGROUND
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease (EVD) outbreaks. This study aimed to assess the protective effect of the vaccine aga...
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease (EVD) outbreaks. This study aimed to assess the protective effect of the vaccine aga...
Journal Article
|Commentary
2024-04-29 • Lancet
2024-04-29 • Lancet
Worldwide, more than 99% of the burden of measles infections and deaths affects populations in low-income and middle-income countries. Measles accounts for 3% of the global mortality of ...
Journal Article
|Research
2024-02-01 • Lancet Infectious Diseases
2024-02-01 • Lancet Infectious Diseases
BACKGROUND
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of ...
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of ...
Journal Article
|Research
2023-01-01 • Lancet Infectious Diseases
2023-01-01 • Lancet Infectious Diseases
BACKGROUND
In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses. We aime...
In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses. We aime...
Journal Article
|Research
2012-06-21 • Bulletin of the World Health Organization
2012-06-21 • Bulletin of the World Health Organization
Malawi has one of the world's highest rates of human immunodeficiency virus (HIV) infection (10.6%), and southern Malawi, where Thyolo district is located, bears the highest burden in th...
Journal Article
|Research
2018-11-08 • PLOS Neglected Tropical Diseases
2018-11-08 • PLOS Neglected Tropical Diseases
Ethiopia bears a high burden of visceral leishmaniasis (VL). Early access to VL diagnosis and care improves clinical prognosis and reduces transmission from infected humans; however, sig...
Journal Article
|Research
2020-02-25 • Vaccine
2020-02-25 • Vaccine
BACKGROUND:
During a measles epidemic, the Ministry of Public Health (MOH) of the Democratic Republic of the Congo conducted supplementary immunization activities (2016-SIA) from Au...
During a measles epidemic, the Ministry of Public Health (MOH) of the Democratic Republic of the Congo conducted supplementary immunization activities (2016-SIA) from Au...
Conference Material
|Video
2020-09-24 • Epicentre Scientific Day Paris 2020
2020-09-24 • Epicentre Scientific Day Paris 2020
Journal Article
|Research
2014-06-21 • Public Health Action
2014-06-21 • Public Health Action
Prevention of mother-to-child transmission 'Option B+' originated in Malawi in 2011 to prevent new infections in infants exposed to the human immunodeficiency virus (HIV). We assessed 12...
Journal Article
|Research
2018-12-03 • Journal of Viral Hepatitis
2018-12-03 • Journal of Viral Hepatitis
GeneXpert® (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point-of-care use in resource-limited conte...